{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:54:43Z","timestamp":1794668083972,"version":"4.9.1"},"reference-count":19,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"unspecified","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Open Heart"],"accepted":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Aortic stenosis is a life-limiting condition for which transcatheter aortic valve implantation (TAVI) is an established therapy. Coronary artery disease (CAD) is frequently found in this patient group and optimal management in these patients remains uncertain.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We sought to examine the association of coexistent CAD on mortality and hospital readmission in patients undergoing TAVI.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this observational cohort study, we examined patients who underwent TAVI and segregated them by the presence of obstructive epicardial CAD. The primary outcome was 3-year mortality with secondary outcomes being readmission for (1) all-causes, (2) a MACE (Major Adverse Cardiovascular Event) composite endpoint and (3) acute coronary syndrome. Subsidiary outcomes included patient angina and breathlessness scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>898 patients underwent TAVI, of which 488 (54.3%) had unobstructed coronary arteries and 410 (45.7%) had obstructive CAD. Overall, n=298 (33.2%) patients experienced the primary mortality endpoint with no significant difference when stratified according to CAD (n=160 (32.9%) vs n=136 (33.2%), HR 0.98,\u2009CI 0.78 to 1.24). After multivariate analysis, the presence of CAD had no effect on the primary outcome (HR 0.98,\u2009CI 0.68 to 1.40). There was no significant difference in readmission for any cause (n=181, 37.1% (CAD) vs n=169, 41.2% (no CAD), p=0.23), including no significant difference on readmission for MACE (n=48, 9.8% (CAD) vs n=45, 11.0% (no CAD), p=0.11). CAD at the time of TAVI also did not alter breathlessness or angina scores before\/after TAVI (p&gt;0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Coexistent CAD had no significant association with mortality, any-cause readmission or symptoms for patients undergoing TAVI in our cohort.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/openhrt-2024-002620","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T12:15:38Z","timestamp":1711714538000},"page":"e002620","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Coronary artery disease and outcomes following transcatheter aortic valve implantation"],"prefix":"10.1136","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2923-6745","authenticated-orcid":false,"given":"Sameer","family":"Kurmani","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavik","family":"Modi","sequence":"additional","affiliation":[{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya","family":"Mukherjee","sequence":"additional","affiliation":[{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Adlam","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amerjeet","family":"Banning","sequence":"additional","affiliation":[{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ladwiniec","sequence":"additional","affiliation":[{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Rajendra","sequence":"additional","affiliation":[{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Baron","sequence":"additional","affiliation":[{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elved","family":"Roberts","sequence":"additional","affiliation":[{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Squire","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"},{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"McCann","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilesh J","family":"Samani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Kovac","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"},{"name":"Glenfield Hospital, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,3,29]]},"reference":[{"key":"2025081711152308000_11.1.e002620.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103510"},{"key":"2025081711152308000_11.1.e002620.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1814052"},{"key":"2025081711152308000_11.1.e002620.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.08.005"},{"key":"2025081711152308000_11.1.e002620.4","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jtcvs.2013.06.046","article-title":"Assessment of coronary artery disease risk in 5463 patients undergoing cardiac surgery: when is preoperative coronary angiography necessary?","volume":"146","author":"Thalji","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2025081711152308000_11.1.e002620.5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ejcts\/ezx324","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"52","author":"Falk","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2025081711152308000_11.1.e002620.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2014.02.537"},{"key":"2025081711152308000_11.1.e002620.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.01.096"},{"key":"2025081711152308000_11.1.e002620.8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005960","article-title":"Transcatheter aortic valve implantation with or without percutaneous coronary artery revascularization strategy: a systematic review and meta-analysis","volume":"6","author":"Kotronias","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025081711152308000_11.1.e002620.9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/JAHA.117.006092","article-title":"Impact of coronary artery disease on 30-day and 1-year mortality in patients undergoing transcatheter aortic valve replacement: a meta-analysis","volume":"6","author":"Sankaramangalam","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025081711152308000_11.1.e002620.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2013.03.062"},{"key":"2025081711152308000_11.1.e002620.11","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.jcin.2021.06.041","article-title":"ACTIVATION (PercutAneous coronary inTervention prIor to transcatheter aortic valve implantaTION): a randomized clinical trial","volume":"14","author":"Patterson","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2025081711152308000_11.1.e002620.12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa070829"},{"key":"2025081711152308000_11.1.e002620.13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915922"},{"key":"2025081711152308000_11.1.e002620.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy394"},{"key":"2025081711152308000_11.1.e002620.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008232"},{"key":"2025081711152308000_11.1.e002620.16","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(19)33019-0"},{"key":"2025081711152308000_11.1.e002620.17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1161\/CIRCINTERVENTIONS.116.004088","article-title":"Functional assessment of coronary artery disease in patients undergoing transcatheter aortic valve implantation: influence of pressure overload on the evaluation of lesions severity","volume":"9","author":"Pesarini","year":"2016","journal-title":"Circ Cardiovasc Interv"},{"key":"2025081711152308000_11.1.e002620.18","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jcin.2022.06.019","article-title":"The effect of coronary lesion complexity and periprocedural revascularization on 5-year outcomes after TAVR","volume":"15","author":"Minten","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"2025081711152308000_11.1.e002620.19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2022.10.009","article-title":"Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation - the third nordic aortic valve intervention trial - NOTION-3","volume":"255","author":"Sabbah","year":"2023","journal-title":"Am Heart J"}],"container-title":["Open Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/openhrt-2024-002620","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,17]],"date-time":"2025-08-17T18:15:36Z","timestamp":1755454536000},"score":1,"resource":{"primary":{"URL":"https:\/\/openheart.bmj.com\/lookup\/doi\/10.1136\/openhrt-2024-002620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,3,29]]},"published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1136\/openhrt-2024-002620"],"URL":"https:\/\/doi.org\/10.1136\/openhrt-2024-002620","relation":{},"ISSN":["2053-3624"],"issn-type":[{"value":"2053-3624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]}}}